Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma

被引:190
作者
Hao, BT
Wang, HJ
Zhou, KX
Li, Y
Chen, XP
Zhou, GQ
Zhu, YP
Miao, XP
Tan, W
Wei, QY
Lin, DX
He, FC [1 ]
机构
[1] Beijing Inst Radiat Med, Lab Syst Biol, Beijing 100850, Peoples R China
[2] Chinese Acad Med Sci, Dept Etiol & Carcinogenesis, Inst Canc, Peking Union Med Coll, Beijing, Peoples R China
[3] Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX USA
[4] Chinese Natl Human Ctr, Beijing, Peoples R China
关键词
D O I
10.1158/0008-5472.CAN-04-0372
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The etiology of esophageal squamous cell carcinoma (ESCC) has been shown to be associated with genetic and certain environmental factors that produce DNA damage. Base excision repair (BER) genes are responsible for repair of DNA damage caused by reactive oxygen species and other electrophiles and therefore are good candidate susceptibility genes for ESCC. We first screened eight BER genes for new and potential functional polymorphisms by resequencing 27 DNA samples. We then identified and genotyped for important tagging single nucleotide polymorphisms (SNPs) in a case-control study of 419 patients with newly diagnosed esophageal cancer and 480 healthy controls by frequency matching on age and sex. The association between genotypes and ESCC risk was estimated by unconditional multivariate logistic regression analysis, and stepwise regression procedure was used for constructing the final logistic regression model. We identified 129 SNPs in the eight BER genes, including 18 SNPs that cause amino acid changes. In the final model, 4 SNPs, including 2 in the coding regions (ADPRT Val762Ala and MBD4 Glu346Lys) and others in noncoding regions (LIG3 A3704G and XRCC1 T-77C), remained as significant predictors for the risk of ESCC. The adjusted odd ratios were 1.25 [95% confidence interval (CI) 1.02-1.53] for the ADPRT 762Ala allele, 1.25 (95% Cl 1.02-1.53) for the MBD4 346 Lys allele, 0.78 (95% Cl 0.63-0.97) for the LIG3 3704G allele, and 1.38 (95% Cl 1.01-1.89) for the XRCC1-77C allele. In addition, we observed a significant gene-gene interaction between XRCC1 Gln399Arg and ADPRT Val762Ala. The results suggest that the polymorphisms in five BER genes may be associated with the susceptibility to ESCC in a Chinese population.
引用
收藏
页码:4378 / 4384
页数:7
相关论文
共 54 条
[1]   Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors [J].
Al-Tassan, N ;
Chmiel, NH ;
Maynard, J ;
Fleming, N ;
Livingston, AL ;
Williams, GT ;
Hodges, AK ;
Davies, DR ;
David, SS ;
Sampson, JR ;
Cheadle, JR .
NATURE GENETICS, 2002, 30 (02) :227-232
[2]   Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency [J].
Bader, S ;
Walker, M ;
Heindrich, B ;
Bird, A ;
Bird, C ;
Hooper, M ;
Wyllie, A .
ONCOGENE, 1999, 18 (56) :8044-8047
[3]   Most microsatellite unstable sporadic colorectal carcinomas carry MBD4 mutations [J].
Bader, S ;
Walker, M ;
Harrison, D .
BRITISH JOURNAL OF CANCER, 2000, 83 (12) :1646-1649
[4]   Role of MED1 (MBD4) gene in DNA repair and human cancer [J].
Bellacosa, A .
JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 187 (02) :137-144
[5]   XRCC1 and DNA strand break repair [J].
Caldecott, KW .
DNA REPAIR, 2003, 2 (09) :955-969
[6]   LDA - a java']java-based linkage disequilibrium analyzer [J].
Ding, KY ;
Zhou, KX ;
He, FC ;
Shen, Y .
BIOINFORMATICS, 2003, 19 (16) :2147-2148
[7]   A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage [J].
El-Khamisy, SF ;
Masutani, M ;
Suzuki, H ;
Caldecott, KW .
NUCLEIC ACIDS RESEARCH, 2003, 31 (19) :5526-5533
[8]   Population attributable risks of esophageal and gastric cancers [J].
Engel, LS ;
Chow, WH ;
Vaughan, TL ;
Gammon, MD ;
Risch, HA ;
Stanford, JL ;
Schoenberg, JB ;
Mayne, ST ;
Dubrow, R ;
Rotterdam, H ;
West, AB ;
Blaser, M ;
Blot, WJ ;
Gail, MH ;
Fraumeni, JF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (18) :1404-1413
[9]  
Franceschi S, 2000, INT J CANCER, V86, P626, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt
[10]  
626::AID-IJC4&gt